Skip to main content
Adam Durbin, MD, Pediatric Hematology & Oncology, Memphis, TN

AdamDavidDurbinMDPh.D.

Pediatric Hematology & Oncology Memphis, TN

Pediatric Solid Tumor Oncology

Assistant Member Division of Molecular Oncology Department of Oncology Developmental Biology and Solid Tumor Program St. Jude Childrens Research Hospital

Dr. Durbin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Durbin's full profile

Already have an account?

  • Office

    262 Danny Thomas Pl
    dtrt 5062F
    Memphis, TN 38105
    Phone+1 901-595-7701

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2012 - 2015
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2012

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2023 - 2026
  • MA State Medical License
    MA State Medical License 2015 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory Circuitry  
    William C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature

Press Mentions

  • Targeting Specific Protein Regions Offers a New Treatment Approach in Medulloblastoma
    Targeting Specific Protein Regions Offers a New Treatment Approach in MedulloblastomaApril 26th, 2024